Literature DB >> 6290056

Etoposide salvage therapy for refractory germ cell tumors: an update.

S D Williams, L H Einhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6290056     DOI： 10.1016/s0305-7372(82)80081-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Combination salvage chemotherapy using cisplatin and teniposide for patients with refractory germinal testicular tumors.

Authors:  T Kotake; T Miki
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

4.  VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.

Authors:  L H Einhorn
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine (BEPV).

Authors:  B A Price; N H Peters
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.